期刊文献+

人肿瘤坏死因子α抑制肽-抗炎酸性尾巴融合蛋白的原核表达及纯化 被引量:1

Prokaryotic Expression and Purification of Fusion Protein of Human Tumor Necrosis Factor α Inhibitory Peptide and Anti-Inflammatory Acidic Tail
下载PDF
导出
摘要 目的:表达和纯化人肿瘤坏死因子α抑制肽-抗炎酸性尾巴融合蛋白。方法:利用PCR搭接方法及基因合成方法获得目的基因,插入带有6×His标签的原核高效可溶性表达载体pET32a中,构建重组表达质粒pET32a-T9-ac-9,将重组表达质粒转化大肠杆菌BL21(DE3),经IPTG诱导目的基因表达;对融合蛋白进行Ni2+金属螯合柱纯化。结果:构建的重组表达质粒经PCR、内切酶鉴定及基因序列测定证实;目的蛋白在大肠杆菌中获得表达,SDS-PAGE显示相对分子质量为22.917×103;对表达产物进行了亲和层析纯化,从上清中获得了纯度较高的人肿瘤坏死因子α抑制肽-抗炎酸性尾巴融合蛋白。结论:获得了可溶性的人肿瘤坏死因子α抑制肽-抗炎酸性尾巴融合蛋白,为其生物学功能研究奠定了基础。 Objective: To prokaryotic express and purify the fusion protein of human tumor necrosis factor α inhibitory peptide with anti-inflammatory acidic tail in E.coli.Methods: The gene of interest was amplified by overlapping PCR and inserted into the prokaryotic expression vector pET32a with 6×His tag to build recombinant expression plasmid pET32a-T9-ac-9.The recombinant plasmid was transformed into E.coli BL21(DE3),and the expression of fusion protein was induced by IPTG.Ni2+ metal chelating column was utilized for high purification of the target protein.Results: Sequencing and restriction analysis revealed the recombinant plasmid was constructed successfully.The fusion protein was expressed in E.coli,SDS-PAGE showed a clear protein band with a relative molecular weight of 22.917 kD.The expression products were purified by affinity chromatography from ultrasonic supernatant of E.coli.Conclusion: The fusion protein of human tumor necrosis factor α inhibitory peptide with anti-inflammatory acidic tail was successfully expressed and purified,which makes the foundation of further study on its biological function.
出处 《生物技术通讯》 CAS 2011年第6期823-826,共4页 Letters in Biotechnology
关键词 人肿瘤坏死因子Α 抗炎酸性尾巴 抑制肽 基因克隆 表达 tumor necrosis factor α anti-inflammatory acidic tail inhibitory peptide gene cloning expression
  • 相关文献

参考文献11

  • 1Zhang Jie, Zheng Li, Zhao An, et al. Idetification of anti-TNF alpha peptides with consensus sequence [J]. Biochem Biophys Res Commun, 2003,310(4): 1181-1187.
  • 2Wang Q, Zeng M, Wang W, et al. The HMGB1 acidic tail regulates HMGB1 DNA binding specificity by a unique mechanism[J]. Biochem Biophys Res Commun, 2007,360:14-19.
  • 3何江,张杰.重组人TNF-α在大肠杆菌中的表达、纯化及生物学活性研究[J].中国优生与遗传杂志,2004,12(6):28-30. 被引量:3
  • 4刘丽,宋丽华,刘及.人TNFa基因克隆表达及表达产物的纯化和生物学活性分析[J].白求恩医科大学学报,1996,22(5):456-459. 被引量:2
  • 5王梁华,焦炳华.重组人肿瘤坏死因子α衍生物3a的制备及纯化[J].第二军医大学学报,1996,17(4):324-327. 被引量:6
  • 6Conti F, Ceccarelli F, Perricone C, et al. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis{J]. Rheumatology(Oxford), 2011,50(6):1148-52.
  • 7Bellizzi A, Barucca V, Fioriti D, et al. Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation [J]. J Cell Physiol, 2010,224(2): 316-326.
  • 8Zhou W, Hashimoto K, Goleniewska K, et al Prostaglandin 12 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells[J]. J Immunol, 2007,178 (2):702-710.
  • 9Sherry C L, O'Connor J C, Kramer J M, et al. Augmented lipopolysaccharide -induced TNFα production by peritoneal maerophages in type 2 diabetic miee is dependent on elevated glucose and requires p38 MAPK[J]. J Immunol, 2007,178(2): 663-670.
  • 10McCann K L, Imani F. Transforming growth factor beta enhances respiratory syncytial virus replication and tumor necrosis factor α induction in human epithelial cells[J]. J Virol, 2007, 81 (6):2880-2886.

二级参考文献11

共引文献17

同被引文献7

  • 1何江,张杰.重组人TNF-α在大肠杆菌中的表达、纯化及生物学活性研究[J].中国优生与遗传杂志,2004,12(6):28-30. 被引量:3
  • 2龚薇,何凤田,李蓉芬,高会广,张艳,黎松,黄刚.人HMGB1酸性尾端对其抗菌活性的影响[J].中国生物化学与分子生物学报,2006,22(7):524-529. 被引量:1
  • 3Zhang J, Zhang L, Zhang A, et al. Idetification of anti-TNF alpha peptides with consensus sequence[J]. Blochem Biophys Res Commun, 2003,310:1181-1187.
  • 4Komano Y, Tanaka M, Nanki T, et al. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Long-term Safety[J]. J Rheumatol, 2011,38(7):1258-1264.
  • 5Conti F, Ceccarelli F, Perricone C, et al. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis[J]. Rheumatology(Oxford), 2011,50(6):1148-1152.
  • 6Hoffmann A, Mallet M Q, Gloser M, et al. Recombinant production of bioactive human TNF-alpha by SUMO-fusion system-high yields from shake-flask culture[J]. Protein Expr Purif. 2010,72(2):238-243.
  • 7Campas-Moya C.A novel anti-TNF-alpha human monoclonal antibody for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis[J]. Drugs Today(Barc), 2010,46(1):13-22.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部